1-20 of 84
Sebastian Schwind
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Apheresis for Production of Chimeric Antigen Receptor (CAR) T Cells in Patients with Multiple Myeloma - Clinical Factors, Cell Composition and T Cell Senescence

Vladan Vucinic, Janine Kirchberg, Mandy Brueckner, Patrick Born, Luise Fischer, Enrica Bach, Nora Grieb, Simone Heyn, Christina Kloetzer, Klaus H Metzeler, Sandra Hoffmann, Carmen Herling, Marco Herling, Georg-Nikolaus Franke, Sebastian Schwind, Song-Yau Wang, Madlen Jentzsch, Uwe Platzbecker, Maximilian Merz
Journal: Blood
Blood (2023) 142 (Supplement 1): 3521.
https://doi.org/10.1182/blood-2023-182222
Published: 2023
Journal Articles

Impact of Typical and Atypical Complex Karyotype Subgroups on Outcome of AML Patients Undergoing Allogeneic Stem Cell Transplantation

Jule Ussmann, Anne Weigert, Lara Bischof, Dominic Brauer, Donata Backhaus, Claudia Diener, Maximilian Merz, Vladan Vucinic, Klaus H Metzeler, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch
Journal: Blood
Blood (2023) 142 (Supplement 1): 2244.
https://doi.org/10.1182/blood-2023-179713
Published: 2023
Journal Articles

A Novel and Cost-Efficient Measurable Residual Disease (MRD) Detection Assay Using a Single Molecule Molecular Inversion Probe-Based Next Generation Sequencing (NGS) Assay Predicts Overall Survival in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Simon M. Krauß, Tara Holloway, Lara Bischof, Donata Backhaus, Dominic Brauer, Jule Ussmann, Anne Weigert, Georg-Nikolaus Franke, Vladan Vucinic, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch, Klaus H Metzeler
Journal: Blood
Blood (2023) 142 (Supplement 1): 3616.
https://doi.org/10.1182/blood-2023-181728
Published: 2023
Journal Articles

Increased LFS Following Hematopoietic Cell Transplantation As Compared to Conventional Consolidation Therapy in Patients >60 Years with AML in First Complete Remission and a Matched Donor: Results of a Randomized Phase III Study

Dietger Niederwieser, Dirk Hasenclever, Wolfgang E. Berdel, Bart J. Biemond, Haifa Kathrin Al-Ali, Yves Chalandon, Michel Van Gelder, Christian Junghanss, Goesta Gahrton, Mathias Haenel, Rüdiger Hehlmann, Thomas Heinicke, Andreas Hochhaus, Simona Iacobelli, Rien van Marwijk Kooy, Nicolaus Kröger, Jeroen J.W.M. Janssen, Madlen Jentzsch, Frank Breywisch, Mohamad Mohty, Stavroula Masouridi-Levrat, Gert Ossenkoppele, Jakob Passweg, Wolfram Pönisch, Johannes Schetelig, Christoph Schliemann, Sebastian Schwind, Matthias Stelljes, Peter JM Valk, Bob Lowenberg, Jan J. Cornelissen
Journal: Blood
Blood (2022) 140 (Supplement 1): 2126–2129.
https://doi.org/10.1182/blood-2022-157684
Published: 2022
Journal Articles

Prognostic Impact of the 2022 European Leukemia Net Risk Classification in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Madlen Jentzsch, Lara Bischof, Jule Ussmann, Donata Backhaus, Dominic Brauer, Klaus H. Metzeler, Marco Herling, Maximilian Merz, Vladan Vucinic, Georg-Nikolaus Franke, Uwe Platzbecker, Sebastian Schwind
Journal: Blood
Blood (2022) 140 (Supplement 1): 10601–10602.
https://doi.org/10.1182/blood-2022-164842
Published: 2022
Journal Articles

Prognostic Impact of Measurable Residual Clonal Hematopoiesis after Allogeneic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

Lara Bischof, Elizabeth Gaston, Jule Ussmann, Juliane Grimm, Marius Bill, Dominic Brauer, Donata Backhaus, Lisa Herrmann, Maximilian Merz, Marco Herling, Klaus H. Metzeler, Georg-Nikolaus Franke, Vladan Vucinic, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch
Journal: Blood
Blood (2022) 140 (Supplement 1): 7750–7751.
https://doi.org/10.1182/blood-2022-169478
Published: 2022
Journal Articles

Collections of Autologous Lymphocytes for Treatment with Chimeric Antigen Receptor (CAR) T-Lymphocytes - No Association of Clonal Hematopoiesis (CH) with Manufacturing Success

Simon M. Krauss, Konstantin Weibl, Enrica Bach, Mandy Brückner, Anne Weigert, Theresa Tumewu, Florian Ramdohr, Elena Ruschpler, Gunhild Vogtmann, Sandra Hoffmann, Olaf Penack, Martin Janz, Raymund Buhmann, Reinhard Henschler, Lars Bullinger, Ulrich Keller, Sebastian Schwind, Maximilian Merz, Madlen Jentzsch, Georg-Nikolaus Franke, Marco Herling, Uwe Platzbecker, Klaus H. Metzeler, Vladan Vucinic
Journal: Blood
Blood (2022) 140 (Supplement 1): 7560–7562.
https://doi.org/10.1182/blood-2022-163360
Published: 2022
Journal Articles

Outcomes of Patients with Acute Myeloid Leukemia Receiving a Second Allogeneic Stem Cell Transplantation

Jule Ussmann, Lara Bischof, Dominic Brauer, Donata Backhaus, Marco Herling, Klaus H. Metzeler, Maximilian Merz, Vladan Vucinic, Georg-Nikolaus Franke, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch
Journal: Blood
Blood (2022) 140 (Supplement 1): 4819–4820.
https://doi.org/10.1182/blood-2022-169268
Published: 2022
Journal Articles

Quantitative Impact of Mutated NPM1 MRD in Patients with AML Undergoing Allogeneic Stem Cell Transplantation

Sebastian Schwind, Lara Bischof, Marius Bill, Juliane Grimm, Jule Ussmann, Elizabeth Gaston, Donata Backhaus, Dominic Brauer, Marco Herling, Maximilian Merz, Klaus H. Metzeler, Georg-Nikolaus Franke, Vladan Vucinic, Uwe Platzbecker, Madlen Jentzsch
Journal: Blood
Blood (2022) 140 (Supplement 1): 3412–3413.
https://doi.org/10.1182/blood-2022-163365
Published: 2022
Journal Articles

Rapid Response to Idecabtagene Vicleucel in a Myeloma Patient Refractory to Multiple Prior Lines of Anti-BCMA Directed Therapies

Maximilian Merz, Vladan Vucinic, Song Yau Wang, Christina Kloetzer, Birthe Schetschorke, Jan Sonntag, Jule Ussmann, Saskia Hell, Simone Heyn, Sandra Hoffmann, Enrica Bach, Klaus H. Metzeler, Sebastian Schwind, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Uwe Platzbecker
Journal: Blood
Blood (2022) 140 (Supplement 1): 12492–12493.
https://doi.org/10.1182/blood-2022-164591
Published: 2022
Journal Articles

Outcomes Following Hypomethylating Agent / Venetoclax Combination-Therapy for MDS or AML Relapse after Allogeneic Hematopoietic Stem Cell Transplantation

Dominic Brauer, Lara Bischof, Jule Ussmann, Donata Backhaus, Georg-Nikolaus Franke, Vladan Vucinic, Marco Herling, Maximilian Merz, Leanthe Braunert, Doreen Hammerschmidt, Alexander Kühnemund, Anne Weigert, Klaus H. Metzeler, Uwe Platzbecker, Madlen Jentzsch, Sebastian Schwind
Journal: Blood
Blood (2022) 140 (Supplement 1): 4808–4809.
https://doi.org/10.1182/blood-2022-163363
Published: 2022
Journal Articles

Single-Cell Multi-Omics of Peripheral Blood Reveals Tiding and Evolution of Responsive and Resistant Clones upon Daratumumab-Based Treatments in Multiple Myeloma and Plasma Cell Leukemia

Nora Grieb, Jaren Sia, Jonathan Adam Scolnick, Shaun Cordes, Christina Kloetzer, Simone Heyn, Julia Strenge, Theresa Tumewu, Kristen Gerhardt, Kolja Nenoff, Anne Sophie Kubasch, Song Yau Wang, Enrica Bach, Madlen Jentzsch, Georg-Nikolaus Franke, Sebastian Schwind, Klaus H. Metzeler, Marco Herling, Vladan Vucinic, Uwe Platzbecker, Maximilian Merz
Journal: Blood
Blood (2022) 140 (Supplement 1): 4207–4208.
https://doi.org/10.1182/blood-2022-166241
Published: 2022
Journal Articles

Differential Prognostic Relevance of Measurable Residual Disease in Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in First Versus Second Morphologic Remission

Madlen Jentzsch, Johannes Küpper, Dominic Brauer, Donata Backhaus, Julia Schulz, Georg-Nikolaus Franke, Vladan Vucinic, Dietger Niederwieser, Uwe Platzbecker, Sebastian Schwind
Journal: Blood
Blood (2021) 138 (Supplement 1): 416.
https://doi.org/10.1182/blood-2021-144794
Published: 2021
Journal Articles

Diagnostic Red Blood Cell Distribution Width As a Prognostic Factor in Acute Myeloid Leukemia

Vladan Vucinic, Leo Ruhnke, Katja Sockel, Maximilian Alexander Röhnert, Donata Backhaus, Dominic Brauer, Georg-Nikolaus Franke, Dietger Niederwieser, Martin Bornhäuser, Christoph Rollig, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch
Journal: Blood
Blood (2021) 138 (Supplement 1): 1227.
https://doi.org/10.1182/blood-2021-145497
Published: 2021
Journal Articles

Applicability of the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) to Predict Outcomes of Acute Myeloid Leukemia Patients Older Than 60 Years Undergoing Non-Myeloablative Allogeneic Stem Cell Transplantation

Donata Backhaus, Madlen Jentzsch, Dominic Brauer, Julia Schulz, Vladan Vucinic, Georg-Nikolaus Franke, Dietger Niederwieser, Uwe Platzbecker, Sebastian Schwind
Journal: Blood
Blood (2021) 138 (Supplement 1): 1797.
https://doi.org/10.1182/blood-2021-150712
Published: 2021
Journal Articles

Prognostic Impact of Nutritional Status at Diagnosis and Weight Changes in Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Dominic Brauer, Donata Backhaus, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD PhD, Uwe Platzbecker, Madlen Jentzsch, MD, Sebastian Schwind, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 32–33.
https://doi.org/10.1182/blood-2020-134187
Published: 2020
Journal Articles

Clinical Relevance of Morphologic and Molecular Complete Remission in AML Patients Undergoing Reduced Intensity or Non-Myeloablative Conditioning

Madlen Jentzsch, MD, Dominic Brauer, Juliane Grimm, MD, Marius Bill, MD PhD, Donata Backhaus, MD, Julia Schulz, Dietger Niederweiser, MD, Uwe Platzbecker, Sebastian Schwind, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 29.
https://doi.org/10.1182/blood-2020-134102
Published: 2020
Journal Articles

The Prognostic Impact of the Diagnostic CD34+/CD38- Cell Burden and Expression of the Stem Cell Marker GPR56 after Stem Cell Transplantation Depends on the AML Origin

Madlen Jentzsch, MD, Marius Bill, MD PhD, Juliane Grimm, MD, Dominic Brauer, MD, Julia Schulz, Karoline Goldmann, Dietger Niederwieser, MD, Uwe Platzbecker, Sebastian Schwind, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 323.
https://doi.org/10.1182/blood-2019-127544
Published: 2019
Journal Articles

Incidence, Risk Factors, Treatment and Long Term Outcome of Refractory and First Relapse AML Patients in the OSHO Studies

Dietger Niederwieser, MD, Rainer Krahl, PhD, Christoph Kahl, MD, Hans-Heinrich Wolf, MD, Sebastian Scholl, Michael Cross, PhD, Ute Hegenbart, MD, Norma Peter, MD, Christian Niederwieser, MD, Axel Florschütz, Kolija Reifenrath, Niklas Zojer, Christian Jakob, MD, Christian Junghanss, MD, Herbert G. Sayer, MD PhD, Volker Schmidt, Sebastian Schwind, MD, Georg Maschmeyer, MD, Thomas Fischer, MD, Andreas Hochhaus, MD, Haifa Kathrin Al-Ali, MD, Thomas Heinicke, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1358.
https://doi.org/10.1182/blood-2019-125262
Published: 2019
Journal Articles

Genome-Wide Association Study (GWAS) Identifies a Significant Acute Myeloid Leukemia (AML) Susceptibility Locus Near BICRA

Christopher J. Walker, PhD, Christopher C. Oakes, Luke K Genutis, BS, Brian Giacopelli, BS, Sandya Liyanarachchi, MS, Deedra Nicolet, MS, Ann-Kathrin Eisfeld, MD, Markus Scholz, PhD, Pamela Brock, MS, LGC, Jessica Kohlschmidt, PhD, Krzysztof Mrózek, MDPhD, Marius Bill, MD PhD, Andrew J. Carroll, PhD, Jonathan E. Kolitz, MD, Bayard L. Powell, MD, Eunice S. Wang, MD, Dietger Niederwieser, MD, Richard M. Stone, MD, John C. Byrd, MD, Sebastian Schwind, MD, Albert de la Chapelle, MD PhD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 85.
https://doi.org/10.1182/blood-2018-99-115170
Published: 2018